Page 1 of Clinical Trials for GVHD, 979 Total Matches
- 1Not yet recruitingLast Updated: August 14, 2008Condition(s): Graft vs Host Disease
- 2RecruitingLast Updated: March 14, 2012Condition(s): Graft-Versus-Host Disease; GVHD; Allogeneic Hematopoietic Transplant; Disorder Related to Transplantation
- 3TerminatedLast Updated: July 21, 2009Condition(s): Graft vs Host Disease; Alogenic Hematopoietic Transplant
- 4RecruitingLast Updated: October 10, 2011Condition(s): Graft Versus Host Disease
- 5RecruitingLast Updated: November 14, 2011Condition(s): Graft Versus Host Disease
- 6CompletedLast Updated: December 19, 2008Condition(s): Graft Versus Host Disease
- 7CompletedLast Updated: August 3, 2009Condition(s): Acute Myelogenous Leukemia (AML); Acute Lymphocytic Leukemia (ALL); Graft vs. Host Disease (GvHD)
- 8Not yet recruitingLast Updated: May 9, 2012Condition(s): Graft Versus Host Disease
- 9RecruitingLast Updated: February 13, 2012Condition(s): Hematologic Malignancies; Graft vs Host Disease
- 10RecruitingLast Updated: January 13, 2011Condition(s): Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes
- 11RecruitingLast Updated: March 23, 2011Condition(s): Leukemia, Myeloid, Accelerated Phase; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Blast Phase; Contiguous Stage II Adult Burkitt's Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; De Novo Myelodysplastic Syndromes; Mucosa-Associated Lymphoid Tissue Lymphoma; Graft Versus Host Disease; Monocytoid B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt's Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt's Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Recurrent; Cutaneous T-cell Lymphoma Recurrent; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Recurrent; Recurrent Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Recurrent; B-cell Small Lymphocytic Lymphoma Recurrent; Chronic Lymphocytic Leukaemia Refractory; Chronic Myelogenous Leukemia in Relapse; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone B-Cell Lymphoma; Stage I Adult Burkitt's Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Stage I; Chronic Lymphocytic Leukaemia Stage 1; Cutaneous T-cell Lymphoma Stage I; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Stage I; Stage I Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Stage I; B-cell Small Lymphocytic Lymphoma Stage I; Adult T-cell Lymphoma/Leukaemia Stage II; Chronic Lymphocytic Leukaemia Stage 2; Cutaneous T-cell Lymphoma Stage II; Mycosis Fungoides/Sezary Syndrome Stage II; Stage III Adult Burkitt's Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Stage III; Chronic Lymphocytic Leukaemia Stage 3; Cutaneous T-cell Lymphoma Stage III; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Stage III; Stage III Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Stage III; B-cell Small Lymphocytic Lymphoma Stage III; Stage IV Adult Burkitt's Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Adult T-cell Lymphoma/Leukaemia Stage IV; Chronic Lymphocytic Leukaemia Stage 4; Cutaneous T-cell Lymphoma Stage IV; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Mantle Cell Lymphoma Stage IV; Stage IV Marginal Zone Lymphoma; Mycosis Fungoides/Sezary Syndrome Stage IV; B-cell Small Lymphocytic Lymphoma Stage IV; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Waldenstrom Macroglobulinemia
- 12RecruitingLast Updated: March 1, 2011Condition(s): Graft Versus Host Disease
- 13Not yet recruitingLast Updated: May 9, 2012Condition(s): Acute Graft Versus Host Disease
- 14Not yet recruitingCannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell TransplantationLast Updated: June 28, 2011Condition(s): Graft Versus Host Disease
- 15Not yet recruitingLast Updated: January 18, 2012Condition(s): Graft-vs-Host Disease
- 16Active, not recruitingLast Updated: January 24, 2012Condition(s): Graft-vs-Host Disease
- 17RecruitingLast Updated: April 11, 2012Condition(s): Leukemia; Lymphoma
- 18RecruitingLast Updated: April 18, 2012Condition(s): Oral Chronic Graft vs Host Disease
- 19CompletedLast Updated: November 6, 2006Condition(s): Graft vs Host Disease
- 20CompletedLast Updated: January 24, 2008Condition(s): Graft vs Host Disease
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=GVHD
